Abridge
About Abridge
Abridge is a healthcare AI company that uses generative AI to transcribe and summarize doctor-patient conversations, automatically generating clinical notes to reduce physicians' paperwork burden.
Funding Rounds
| Round | |||
|---|---|---|---|
| Jun 12, 2025 | Series E | $309.5M | $5.3B |
| Feb 17, 2025 | Series D | $250M | $2.75B |
| Nov 14, 2024 | Series D | $293.2M | - |
| Feb 22, 2024 | Series C | $153.49M | $850M |
| Oct 26, 2023 | Series B | $30M | $232.25M |
| Jun 27, 2023 | Series B | $32.5M | $200M |
| Aug 11, 2022 | Series A-1 | $12.5M | $144.48M |
| Mar 14, 2022 | Series A-1 | $19M | - |
| Oct 6, 2020 | Series A | $10.16M | $102.98M |
| Mar 26, 2020 | Series A | $10.16M | - |
| Jan 31, 2019 | Series Seed | $5.32M | $26.59M |
Perpetual Markets
No perpetual markets available.
Token Issuers
No token issuer markets available.
Valuation and funding data updated Aug 25, 2026, 12:24 PM UTC.
Market data updated Aug 25, 2026, 12:24 PM UTC.